We then performed cell viability assay for AMG510, and MRTX849 in different cancer types (NSCLC, CRC, and pancreatic cancer) including KRAS wild type, KRAS non‐G12C mutation, and KRAS G12C mutation cell lines. The gene discussed is KRAS; the disease is pancreatic neoplasm.